Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders Deficit - Stock Compensation Activity (Details)

v3.24.0.1
Note 7 - Stockholders Deficit - Stock Compensation Activity (Details)
 3 Months Ended
Dec. 31, 2023
USD ($)
$ / shares
shares
Outstanding, Option Shares Outstanding (in shares) 102,125
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 38
Awarded, Option Shares Outstanding (in shares) 0
Forfeited/Cancelled, Option Shares Outstanding (in shares) (1,825)
Outstanding, Option Shares Outstanding (in shares) 100,300
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 38
Outstanding, Weighted Average Remaining Contractual Term (Year) 4 years
Outstanding, Aggregate Intrinsic Value | $ $ 11,000
Vested, Option Shares Outstanding (in shares) 86,119
Vested, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 42
Vested, Weighted Average Remaining Contractual Term (Year) 3 years 6 months
Vested, Aggregate Intrinsic Value | $ $ 0
Vested and expected to vest, Option Shares Outstanding (in shares) 100,300
Vested and expected to vest, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 38
Vested and expected to vest,Weighted Average Remaining Contractual Term (Year) 4 years 6 months
Vested and expected to vest, Aggregate Intrinsic Value | $ $ 0